Effect of a Drinkable Yogurt Enriched in Proteins and Fibers on Satiety
NCT ID: NCT01304004
Last Updated: 2013-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2010-10-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The general objective of the study is to investigate in a pilot study the impact of a drinkable yogurt enriched in proteins and fibres on satiety.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Enriched Yogurts With Soluble Fibre or Vegetable Protein on Satiety
NCT03625245
Full-fat Dairy Products, Body Weight Control and Metabolic Health
NCT05417347
The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control
NCT04399460
Effect of Pre-meal Serving of Dairy and Dairy Alternatives on Post-meal Satiety and Glycaemia in Healthy Young Adults
NCT04600128
Repetitive Lipid Intake and Food Intake
NCT03901157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Experimental drinkable yogurt enriched in proteins and fibres
2. Placebo drinkable yogurt (isocaloric and isovolumetric)
One the eve of the two tests, participants will consume the same meal at dinner time. During the test days, participants should arrive between 6:30 and 8:30 and will be isolated in a private room suitable for this type of testing. Any reference to time of the day will be eliminated until the end of tests. First, participants will consume a standardized breakfast which corresponds to about 10 to 15% of energy needs of the day. The food provided at breakfast (toast, butter, peanut butter, cheese, orange juice) will be the same in both tests. Participants must consume all food within a period of 15 minutes. Two hours after the start of the test, participants will receive a snack in the form of yogurt (experimental, placebo) they will consume within a period of 5 minutes. Two hours later, participants will receive a lunch buffet consists of food ready to eat. The foods present in the buffet will have an overall energy value of about 1500 kcal, which exceeds the energy needs of participants for this meal. They will be encouraged to consume foods until satiety over a maximum of 30 minutes.
Satiety will be measured by visual analogue scale throughout the test, either immediately before breakfast and snack as well as predetermined times thereafter until the lunch. Participants will have access to water throughout the test. The weight of food consumed and the water intake will be calculated in the absence of the participants and will be used to calculate the energy intake at lunch.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental drinking yogurt
Satiety
Intervention Description: Consumption of the 2 drinkable yogurts separated by 4 weeks:
1. Experimental drinkable yogurt enriched in proteins and fibres
2. Placebo drinkable yogurt (isocaloric and isovolumetric)
Placebo drinking yogurt
Satiety
Intervention Description: Consumption of the 2 drinkable yogurts separated by 4 weeks:
1. Experimental drinkable yogurt enriched in proteins and fibres
2. Placebo drinkable yogurt (isocaloric and isovolumetric)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Satiety
Intervention Description: Consumption of the 2 drinkable yogurts separated by 4 weeks:
1. Experimental drinkable yogurt enriched in proteins and fibres
2. Placebo drinkable yogurt (isocaloric and isovolumetric)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index between 20 and 30 kg/m2
* Stable body weight (+/- 2 kg) for 6 months before the beginning of the study
* Smoking or not
Exclusion Criteria
* High blood pressure (≥ 140/90)
* Previous history of repeated weight loss and weight gain
* Important weight loss during the 6 months before the beginning of the study
* Subjects with high restriction level according to established criteria of a questionnaire that measures restriction level
* Use of natural products or supplements having effects on dietary intake during the 3 months
* Pregnant women
* Subjects taking medications for hypertension, depression, hyperlipidemia or immunosuppressant
* Allergy or intolerance to dairy products
* Vegetarism
25 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aliments ULTIMA Foods Inc.
INDUSTRY
Laval University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benoit Lamarche
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoît LAmarche, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute of Nutraceutical and Functional Foods (INAF), Laval University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Nutraceutical and Functional Foods (INAF), Laval University
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INAF-2010-154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.